News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,221 Results
Type
Article (7997)
Company Profile (142)
Press Release (477811)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166750)
Career Advice (304)
Deals (25739)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238204)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33159)
ALS (112)
Alzheimer's disease (986)
Antibody-drug conjugate (ADC) (286)
Approvals (10421)
Artificial intelligence (339)
ASCO (159)
Autoimmune disease (224)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6959)
BIO (36)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (116)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (521)
Cancer (3781)
Cardiovascular disease (227)
Career advice (245)
Career pathing (1)
CAR-T (179)
CDC (1)
CDMO (20)
Celiac Disease (1)
Cell therapy (491)
Cervical cancer (35)
Clinical research (48078)
Collaboration (1286)
Commercialization (3)
Compensation (1538)
Complete response letters (34)
COVID-19 (762)
CRISPR (64)
C-suite (810)
Cystic fibrosis (87)
Data (5899)
Denatured (4)
Depression (107)
Dermatology (71)
Diabetes (359)
Diagnostics (4226)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73754)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88158)
Executive appointments (716)
FDA (12522)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (952)
Gene editing (126)
Generative AI (11)
Gene therapy (336)
GLP-1 (295)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9368)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (70)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (164)
Infectious disease (954)
Inflammatory bowel disease (129)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (264)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (46)
Layoffs (59)
Legal (5195)
Licensing (20)
Liver cancer (45)
Longevity (19)
Lung cancer (549)
Lymphoma (259)
Machine learning (29)
Management (3)
Manufacturing (579)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8685)
Medtech (8845)
Mergers & acquisitions (14415)
Metabolic disorders (733)
mRNA (65)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (40)
Neuroscience (1881)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (234)
Opinion (10)
Ovarian cancer (161)
Pain (178)
Pancreatic cancer (207)
Parkinson's disease (207)
Partnered (12)
Patents (504)
Patient recruitment (533)
Patient selection (2)
Peanut (32)
People (41378)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15521)
Phase 2 (21466)
Phase 3 (14484)
Pipeline (7776)
Policy (18)
Postmarket research (1570)
Preclinical (6555)
Press Release (34)
Prostate cancer (193)
Psychedelics (8)
Radiopharmaceuticals (195)
Rare diseases (593)
Real estate (3026)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14999)
Reports (23)
Research institute (586)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (165)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (335)
Venture capital (17)
Weight loss (75)
Women's health (90)
Date
Today (65)
Last 7 days (284)
Last 30 days (1486)
Last 365 days (19095)
2026 (13842)
2025 (19251)
2024 (22987)
2023 (26539)
2022 (34587)
2021 (37150)
2020 (33470)
2019 (23258)
2018 (17472)
2017 (18770)
2016 (17918)
2015 (24263)
2014 (21676)
2013 (18135)
2012 (20202)
2011 (20440)
2010 (20332)
Location
Africa (229)
Alabama (79)
Alaska (2)
Arizona (312)
Arkansas (11)
Asia (17978)
Australia (2109)
California (12404)
Canada (3254)
China (550)
Colorado (503)
Connecticut (428)
Delaware (215)
Europe (24701)
Florida (1866)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (733)
India (52)
Indiana (325)
Iowa (16)
Japan (431)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1234)
Massachusetts (8125)
Michigan (315)
Minnesota (573)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (123)
New Hampshire (60)
New Jersey (2712)
New Mexico (12)
New York (2910)
North Carolina (1321)
North Dakota (4)
Northern California (6237)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2305)
Puerto Rico (23)
Rhode Island (30)
South America (406)
South Carolina (78)
South Dakota (1)
Southern California (5168)
Tennessee (125)
Texas (2023)
United States (40210)
Utah (377)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (958)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
486,221 Results for "lakepharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Integrity Bio and LakePharma Become Curia
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced that Integrity Bio and LakePharma, two companies that it acquired last year, have fully transitioned to the Curia brand.
February 14, 2022
·
2 min read
Deals
Curia Completes Acquisition of LakePharma
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has completed the transaction to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with operations in California, Massachusetts and Texas
September 2, 2021
·
2 min read
Deals
Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics
Curia announced it has entered into a definitive agreement to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with operations in California, Massachusetts, and Texas.
July 14, 2021
·
4 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
Business
Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine
Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a leading U.S.-based CRDMO serving the biotechnology community with development and production services, announced today that they have established a strategic partnership.
January 5, 2021
·
3 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Business
LakePharma Announces Expansion into the Dallas/Fort Worth Metroplex
The new location allows LakePharma to better align its services with clients’ demands in the rapidly growing biologics industry.
July 23, 2019
·
1 min read
Biotech Bay
LakePharma Provides Recombinant COVID-19 Proteins to Facilitate Antibody And Diagnostic Development Against COVID-19
LakePharma today announced that the company has made various versions of recombinant COVID-19 spike proteins using rapid CHO manufacturing platforms.
March 31, 2020
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
1 of 48,623
Next
